![](/img/cover-not-exists.png)
174PD A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare)
Zhang, T., Zhu, J., Chen, J.Y., Zhu, Y., Zhou, J., Zhu, Y., Jia, J.H., Zhang, C., Wang, X., Gao, Y.H., Cai, G., Luo, B., Wu, J., Liu, A., Xu, B., Zhang, Z.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw581.006
Date:
December, 2016
File:
PDF, 75 KB
2016